Keyur B. Shah (@keyurbshahric) 's Twitter Profile
Keyur B. Shah

@keyurbshahric

VCU Cardiologist, Wahoo, Helpless Detroit Lions fan, opinions are my own.

ID: 751288712

calendar_today11-08-2012 13:43:25

265 Tweet

475 Takipçi

416 Takip Edilen

Keyur B. Shah (@keyurbshahric) 's Twitter Profile Photo

#nurses : Interested in a career in #heartfailure ? Consider joining our growing team as #LVAD RN Coordinator VCU Health Pauley Heart Center ICCAC Apply here --> vcuhealth.wd1.myworkdayjobs.com/en-US/VCUHealt…

Cardiovascular Research Foundation (@crfheart) 's Twitter Profile Photo

🔍 Get the latest updates on amyloid heart disease! Stay ahead of the curve and deepen your understanding of this critical topic. Only at #THT2024! 💡 Jan Griffin @Mathew.Maurer Sharmila Dorbala Parag Goyal MD MSc Michel Khouri @reyentovichHFMD @KeyurBShahRic @mazhanna #CardioEd

🔍 Get the latest updates on amyloid heart disease! Stay ahead of the curve and deepen your understanding of this critical topic. Only at #THT2024! 💡

<a href="/JanMGriffin/">Jan Griffin</a> @Mathew.Maurer <a href="/DorbalaSharmila/">Sharmila Dorbala</a> <a href="/ParagGoyalMD/">Parag Goyal MD MSc</a> <a href="/MGKhouri_md/">Michel Khouri</a> @reyentovichHFMD @KeyurBShahRic @mazhanna #CardioEd
Keyur B. Shah (@keyurbshahric) 's Twitter Profile Photo

We have 2✌️positions for ADV HF cardiologists interested in clinical-academic career. Join a growing 🫀TX team VCU Health Pauley Heart Center @vcuhealth in Ric, VA!! Email [email protected] OR apply at below: vcu.csod.com/ux/ats/careers… vcu.csod.com/ux/ats/careers…

American College of Cardiology (@accintouch) 's Twitter Profile Photo

🔑 Tachycardia-induced cardiomyopathy is characterized by a dilated CM w/ moderate to severe biventricular systolic dysfunction and lack of hypertrophy. Mitral insufficiency may be present. Read more key points from a state-of-the-art review on AiCM: bit.ly/4e8Mkgn

🔑 Tachycardia-induced cardiomyopathy is characterized by a dilated CM w/ moderate to severe biventricular systolic dysfunction and lack of hypertrophy. Mitral insufficiency may be present.

Read more key points from a state-of-the-art review on AiCM: bit.ly/4e8Mkgn
Alnylam Pharmaceuticals (@alnylam) 's Twitter Profile Photo

We are pleased to share positive topline results from our HELIOS-B Phase 3 study of vutrisiran, an investigational #RNAi therapeutic in development for the treatment of #ATTR #amyloidosis w/ cardiomyopathy. Read the press release: bit.ly/3VwvRtY #RNAiTherapeutics #siRNA

Keyur B. Shah (@keyurbshahric) 's Twitter Profile Photo

Impressive, practice changing results (including improved survival) in a contemporary #ATTR cohort. Now on to the challenges of ensuring widespread access to therapies…

Keyur B. Shah (@keyurbshahric) 's Twitter Profile Photo

Important day for #ATTR #amyloidosis patients with approval of acoramidis. ❤️ BridgeBio Pharma announcement “To honor the courage of our U.S. clinical trial participants, BridgeBio will provide these patients Attruby free for life” investor.bridgebio.com/news-releases/…

Keyur B. Shah (@keyurbshahric) 's Twitter Profile Photo

IM PGY-3s and beyond: interested in a year of cardiology focus/fellowship prep? Consider one of our two Heart Failure Scholar positions VCU Health Pauley Heart Center Enriched with QI, Scholarly Activities and Clinical preparation. Apply below (DM or email with ?s) vcu.csod.com/ux/ats/careers…

Keyur B. Shah (@keyurbshahric) 's Twitter Profile Photo

🚨 Calling all future Heart Failure specialists! 🚨 Looking for comprehensive , fellow centric, advanced HF training—and want to do it with a team that loves working together—look no further than VCU! Fun included. Apply now via ERAS! #CardioTwitter #MedTwitter VCU Health Pauley Heart Center

🚨 Calling all future Heart Failure specialists! 🚨
Looking for comprehensive , fellow centric, advanced HF training—and want to do it with a team that loves working together—look no further than VCU! 
Fun included. Apply now via ERAS! #CardioTwitter #MedTwitter <a href="/VCUHealthHeart/">VCU Health Pauley Heart Center</a>